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Fusion of Sendai virus with the 
target cell membrane 
is required for T cell cytotoxicity 
INFECTION of mice with viruses can generate cytotoxic T 
lymphocytes (CTL) which show restricted specificity for target 
celllysis, Specific lysis requires that the virus used to prime the 
target cells must be of the same type as that used to sensitise 
the CfL, and that both target and CfL cells must express the 
same major histocompatability complex (MHC) gene pro-
duct(s). The nature of the viral gene product(s) and their inter-
action with the MHC gene product(s) have been the subject of 
recent studyl-5 , Previously we used Sendai virus 10 show that 
lysable target cells can be obtained using membrane vesic\es 
which contain only the viral glycoproteins, indicating thaI these 
may be the specific viral gene products involved in target 
formation s. Sendai virus contains two glycoproteins-the 
haemagglutinin-neuraminidase (HANA) which promotes 
attachment of virus to cells and the fusion pro tein (F) wh ich is 
involved in subsequent virus cell fusion7 - 9 • Both activities are 
necessary fOT insertion of these viral glycoproteins into the 
plasma membrane of the cell to. In this letter we suggest that the 
insertion of the viral glycoproteins into the cell membrane is an 
essential step in target cell formation since we can show that 
virus containing an inactive fusion protein precursor (Fo) 
cannot elicit T cell cytotoxicity unless the fusion activity is 
generated by proteolytic c\eavage of the precursor. Sugamura 
et al. 6 have suggested that it is primarily the F glycoprotein of 
the Sendai virus envelope which is essential for the formation 
of the target antigen, as virus lacking the functional activities of 
F following trypsin digestion was inactive in priming target cells 
fOT T cell killing, However, we show that proteolytic inactiva-
tion of either of the two glycoproteins (F or HANA) of virus 
used to prime target cells will abolish the cytotoxic response. 
Virus-specific effector cells bearing the surface markers 
Thy 1+, Ly 2+2+ and L 6+ (M. Horton et al., in preparation) 
were generated in vitro by secondary stimulation5 of in vivo 





Fig. 1 Dilution curve for Sendai virus-specific T cell-mediated 
cytolysis. P-815 ceHs were incubated with ß-propiolactone-
treated Sendai virus for 1 h at 37°C and washed three times with 
medium, Susceptibility to Sendai virus specific CfLs was 
measured by the 5lCr release assay described previously using 104 
target cells per weHs. Results are from triplicate assays; s,d. were 
always less than 3. Spontaneous lysis was 12% and has been 
subtracted. 0, Lysis of sler labelIed P-81S-Sendai virus treated 
ceHs; . , lysis of untreated P-815 cells, 
piolactone-inactivated) Send ai virus (20,.,.g virus protein per 
106 cells). In experiments designed to calibrate the cytotoxic 
assay, the degree of lysis was shown (Fig, 1 a) to be related to 
virus concentration over the range 0.16-4,.,.g of virus protein 
using 106 P-815 target ceIls, corresponding to approximately 
104_105 virus particles per cell, Amounts of virus greater than 
4 ,.,.g did not increase the degree of lysis. Thus investigations of 
changes in target formation by different virus preparations 
must be carried out in a concentration range which gives a 
linear response in the assay. 
In the experiment described above and in previous works we 
have used egg-grown Send ai virus wh ich is active in fusion . To 
investigate further the role of virus-cell fusion in target cell 
formation we purified Sendai virus produced in MDBK cells. 
This virus contains Fo and is inactive in fusion and non-
infectious although it contains an active HANA glycoprotein 
and can attach to the cell surface9 • Activation of fusion requires 
proteolytic cIeavage of the Fu• When Sendai virus is grown in 
embryonated eggs this c1eavage presumably occurs at the 
plasma membrane. In MDBK cells this c1eavage does not occur 
but MDBK grown virus can be c1eaved in vitro by low concen-
trations of trypsin with restoration of the fusion and haemolytic 
activities and also of infectivity9 , In Table 1 the haemag-
glutinin, neuraminidase, haemolytic and target formation 
activities of trypsin treated MDBK-Sendai are compared with 
those of untreated MDBK-Sendai and egg-grown Sendai virus. 
MDBK-Sendai does not cause significant cell-mediated 
cytolysis (CMC) unless it is activated by pretreatment with 
trypsin, The small amount of target formation obtained with 
MDBK-Sendai is probably due to the small proportion of 
cIeaved F wh ich is always found in these virus preparations, 
These results suggest that MDBK-Sendai virus will not form 
Iysable target cells because the virus and hence the viral glyco-
proteins cannot fuse with the cell membrane , To show that the 
glycoproteins of virus containing Fo can function in target 
formation if they are present in the cell membrane, P-815 cells 
were infected with a low dose (10 EID per cell) of live egg-
grown Sendai virus. This input of virus is too low to cause 
immediate target cell formation but after incubation for 24 h at 
a time when virus containing Fo and HANA was being released 
from the P-815 cells (results not shown) the target cells were 
specifically lysable, However, P-815 cells treated with P-815 
grown Sendai virus were not lysed by T-killer cells unless the 
virus was activated by pretreatment with trypsin to convert Fo 
to F (Table 1). These results further support the hypothesis that 
the process of fusion and membrane insertion of viral glyco-
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proteins is a major requirement for target formation, as virus 
containing Fo can form targets if the viral glycoproteins are 
inserted in the cell membrane from within the cell. 
Although these results suggest that T cell-mediated cytolysis 
requires the presence of viral antigens in the plasma membrane 
it is possible that the T cells might recognise viral antigens that 
are bound to but not fused into the cell surface. In order to try 
to distinguish a recognition phase from a killing phase we have 
used unlabelled target cells having viral antigens either fused 
into the membrane or merely attached to the cell surface to 
compete with SlCr labelIed Sendai-treated target cells for lysis 
by T killer cells. The results shown in Fig. 2 indicate that cells 
coated with MDBK-Sendai virus do not compete for lysis of 
labe lied targets to a greater extent than do normal cells at the 
same density. In contrast, target cells treated with trypsinised 
MDBK-Sendai virus or with egg-grown Sendai virus will 
compete effectively. Thus attachment of virus to target cells is 
insufficient for T-cell recognition as weil as for CMC. 
To investigate further the involvement of the Sendai virus 
glycoproteins in target formation we used limited proteolytic 
digestion of ß-propiolactone-treated virus to selectively 
inactivate the F or HANA glycoproteins. The effect of the 
protease treatments on the viral activities is shown in Table 2. 
Digestion of virus with pronase or the V8 protease of Staphy-
loccus aureus eliminates the haemagglutinin and neuramini-
dase activities, while treatment with trypsin (a concentration 
higher than that required for precursor c\eavage) causes only a 
sm all decrease in these activities. All enzymes abolish the 
fusion and haemolysis activities of the virus. Loss of HA 
activity prevents attachment of virus to cells and thus prevents 
the subsequent virus-<.:ell fusion even if the fusion protein is 
active. Using poly acryl amide gel analysis we have shown that 
pronase c\eaves both Fand HANA while trypsin c\eaves Fand 
the V8 protease removes the HANA. The fusion protein of 
virus treated with V8 protease is indistinguishable from that of 
untreated virus by analysis on polyacrylamide gels, immunolo-
gical analysis and amino acid composition (M.-J. G. and M. W., 
in preparation). Target formation by the protease treated virus 
preparations was evaluated after incubation of 106 P-815 cells 
with modified or untreated virus. The results shown in Table 2 
indicate that inactivation of not only F but also HANA abol-
ishes the capacity of virus to form target cells or reduces it by 
more than 99% . 
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Flg. 2 Inhibition of T cell-mediated cytolysis of Sendai virus-
treated S ICr-Iabelled P-815 cells by competitor P-815 cells treated 
with various Sendai virus preparations. Competitor celIs: " 
P-815 control; 0, P-815 + MDBK-Sendai virus (100 ",g per 106 
cells); ., P-815 + trypsin treated MDBK-Sendai virus 
(100 ",g/106 cells); 0, P-815 +egg Sendai (10 ",g per 106 cells); 
., P-815 +egg Sendai (100 ",g per 106 cells). The cytotoxic test 
was carried out as described in Fig. 1. Killer: target cell ratio 
10: 1. 
The results presented he re show that the capacity of Send ai 
virus to fuse with a target cell is essential for T -cell cytotoxicity. 
This process of fusion results in both the insertion of the viral 
glycoproteins into the cell membrane and also of the viral 
capsid into the cell. We previously reported that noninfectious 
Send ai virus (inactivated by UV light or ß-propiolactone 
treatment) or artificial vesicles containing only the two glyco-
proteins were efficient in target cell formations. We therefore 
suggest that the glycoproteins must be inserted into the cell 
membrane for target formation. We also show that inactivation 
of either of the two glycoproteins of Send ai virus will prevent 
target formation and this interference can be explained by a 
block at the level of virus-<.:ell fusion . These results extend the 
observations of Sugamura et al.6 • Such experiments cannot 
Table 1 Effect of trypsin treatment on the glycoprotein activities of MDBK-Sendai virus 
Cytotoxic assay 
% SICr release Haemolysis Haemagglutinin Neuraminidase 
killer: target ratio activity activity activity 
Virus sampie jLg virus (A S40 per 20 ",g) (HAU per 20 ILg) (A S49 per 20 ILg) 
20: 1 5:1 
Expt 1 
Egg-grown Sendai virus 1 82 74 1.44 2,000 1.18 
10 90 78 
MDBK-grown Sendai virus 10 5 2 0.07 2,000 1.08 
100 15 14 
Trypsin treated MDBK-Sendai virus 100 80 70 1.19 2,000 1.04 
Expt 2 
Egg-grown Send ai virus 1 23 18 1.01 2,000 0.99 
10 42 33 
100 49 35 
P-815 grown Sendai virus 10 0 1 0.02 2,000 1.04 
100 3 2 
Trypsin treated P-815-Sendai virus 10 8 5 0.45 2,000 0.95 
100 15 4 
Purified ß-propiolactone treated MDBK-Sendai virus or P-815-Sendai virus (1 mg in 2 ml phosphate-buffered saline (PBS), pH 7.2) was 
incubaled with trypsin (2.5 ILI, 5 mg ml-' in 1 mM HCI) for 10 min at 37 oe. The reaclion was terminated by addition of soybean trypsin inhibitor 
(10 .... 1,10 mg mi-I in PBS). Contro! sampies of MDBK-Sendai virus and P-815-Sendai virus were treated in exactIy the same manner except for the 
addition of trypsin. Haemagglutinin, neuraminidase and haemolytic activities were assayed as described previousll. The cytotoxic test was carried 
out as described in Fig. 1 legend. Spontaneous lysis from targets was 9-13%. Release from noninfected targets was subtracted. The addition of 
soybean trypsin inhibitor had no effect on the cytotoxic assay. The cytotoxic assays in Expt 2 were carried out with a different batch of CTLs which 
were less active in cytolysis. 
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Table 2 Effect of proteolytic digestion on activities of Sendai virus 
Cytotoxic assay 
% 51 Cr release Fusion activity (per 20 IJ.g) 
killer: target ratio Haemagglutinin N euraminidase Average no. % of nuclei Haemolysis 
Protease 20: 1 5:1 activity activity nuclei in poly- activity 
treatment ILg virus (HAU per (A S49 per 20 ILg) per cell karyocytes (A S40 per 20 ILg) 
20 IJ.g) 
a, No enzyme 0 7 5 
1 86 58 2,048 1.01 5.2 94 1.86 
10 90 62 
b, Trypsin 10 10 7 
100 7 2 2,048 0.94 0 0 0.02 
C, V8 protease 10 10 6 
100 30 12 32 0.03 0 0 0.01 
d, Pronase 10 8 8 
100 14 10 4 0 0 0 0 
ß-PL Sendai virus (2 mg in 1 ml of the appropriate buffer) was digested with proteolytic enzymes as folIows: a, no enzyme; b trypsin (81'01, 
5 mg ml-'; TPCK-treated, Worthington) for 1 h at 37°C in 0.5% ammonium bicarbonate buffer, pH 8. c, V8 protease from Staphylococcus aureus 
(501'01,1 mg ml-'; Miles) for 18 h at 37°C in 50 mM ammonium bicarbonate buffer, pH 8; d, pronase (8 IJ.I, 5 mg ml-1 ; Calbiochem) for 4 h at 37°C 
in PBS buffer. The capacity of the virus preparations to induce target cell formation was measured in the cytotoxic assay described in Fig. 1. 
Haemagglutinin, neuraminidase and haemolytic activities were measured as befores. For cell fusion measurements replicate newly confluent 
cultures of Hep 2 cells in 30 mM plastic Petri dishes were inoculated with 0.1 ml of the virus preparation in PBS containing Ml+ and Ca2+, or were 
mock infected. Following virus adsorbtion for 1 h at 37 oe the cultures were overlaid with 2.0 ml of Dulbecco's reinforced Eagles medium 
containing 10% fetal calf serum. After incubation for 2 h at 37 oe in an atmosphere not enriched with e02 the number of nuclei per 100 cells were 
counted for several fields on each dish. 
determine which glycoprotein is primarily responsible for 
target formation, because both HA and F activities are 
required for virus-cell fusion. Further studies using a tempera-
ture-sensitive HANA - mutant of Sendai virus are in progress 
to elucidate this question. 
Insertion of the viral glycoprotein(s) into the cell membrane 
may be required to facilitate interaction with the MHe gene 
products. However, at this stage there is no evidence to dis-
criminate between the hypotheses of one or two T -cell receptor 
mechanisms, that is, whether the viral glycoprotein(s) interact 
directly with the MHC antigens or whether they act as 
independent antigens for T -cell recognition. 
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Mapping of H -2 genes associated 
with T cell-mediated cytotoxic 
responses to SV40-
tumour-associated specific antigens 
T CELL-MEDIA TED cytotoxic responses to cells carrying viral 
antigens\ haptens2 and male H-Y antigen3 , as weIl as minor 
histocompatibility antigens4 are known to be associated with 
either the K or D region of the murine major histocom-
patibility complex (H-2). Similarly, T ceIl-mediated cytolysis 
of SV 40-transformed cells expressing tumour-assoeiated spe-
eific antigens (TASA) is restricted to syngeneic target cellss-8 . 
Although good cytotoxic responses to SV40-transformed cells 
can be found in mice of H _2 b haplotype after primary in vivo 
immunisationS, the response of mice of other H-2 haplotypes 
is quite poor (unpublished observations), but can be readily 
demonstrated after in vitro6-8 mixed cell cultures. We demon-
strate here primary cytotoxic responses to SV40-TASA in 
various inbred mouse strains using an immunisation protocol 
previously applied to the primary in vivo induction of hapten-
specific9 and virus-specific cytotoxic T lymphocytes (CTL)10. 
Moreover, the availability of appropriate congeneic recom-
binant mice as responders and SV40-transformed cells from 
these mouse strains as target ceIls, has enabled us to map the 
anti-SV40-TASA response within the H-2 complex. The data 
establish that the response is restricted to H -2K or H -2D, and 
indicate the existence of a possible Ir gene inftuence on the 
T-cell response to SV40-TASA associated with H-2D d • 
BlO and BALB/c mice were immunised with SV40 (legend 
to Fig, 1), The kinetics of the CTL generation were studied by 
varying the time of in vivo immunisation (Fig, 1) as weIl as the 
in vitro culture period (Fig. 2). Antigenic specificity of the CTL 
was investigated using SV40- and adenovirus 5-transformed 
cells as targets for the s'Cr release assay. Maximum cytotoxic 
activity was obtained in BIO and BALB/c mice 7 d after in vivo 
immunisation followed by a further 3 d in vitro culture period 
(Figs 1, 2), In accordance with earlier resultsS, CTL could be 
demonstrated in BIO mice when tested directly 7 d after 
immunisation, whereas at that time, BALB/c lymphocytes did 
not mediate specific lysis of the same SV40-transformed 
(BALB/cx C57BL/6) F1 target cells (Fig. 2, day 0 in vitro). 
However, after a 3 d in vitro incubation without addition of 
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